Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity
- PMID: 1992938
- PMCID: PMC1358384
- DOI: 10.1097/00000658-199102000-00006
Mastectomy following preoperative chemotherapy. Strict operative criteria control operative morbidity
Abstract
The surgical morbidity associated with aggressive preoperative chemotherapy in 106 patients with advanced primary breast cancer who had chemotherapy followed by mastectomy was examined. These patients were compared with a group of 91 consecutive patients who had mastectomy without preoperative chemotherapy. Strict operative criteria were used to determine the timing of mastectomy following chemotherapy. Wound infection rates were no different in the preoperative chemotherapy group compared to the mastectomy-alone groups (7% versus 4%; p = 0.62). The incidence of wound necrosis was similar (11% versus 6%; p = 0.29). Seroma formation was decreased significantly in the preoperative chemotherapy group compared to the mastectomy-alone group (15% versus 28%; p = 0.04). Intensive preoperative chemotherapy did not delay the reinstitution of postoperative treatment (30% versus 20%; p = 0.27). However, when delay in instituting postoperative chemotherapy was more than 30 days, there was a significant decrease in overall survival rate (p = 0.04). This study provides evidence that intensive preoperative chemotherapy and mastectomy can be performed without increased morbidity. Furthermore it is important to institute systemic chemotherapy within 30 days of mastectomy to achieve maximum survival.
Comment in
-
Mastectomy following preoperative chemotherapy.Ann Surg. 1992 Jan;215(1):88-9. Ann Surg. 1992. PMID: 1571043 Free PMC article. No abstract available.
Similar articles
-
Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer.Am Surg. 1990 Jan;56(1):6-11. Am Surg. 1990. PMID: 2153011
-
[Preoperative systemic chemotherapy (FAC) in 3 cases of advanced breast cancer].Gan To Kagaku Ryoho. 1986 Sep;13(9):2864-6. Gan To Kagaku Ryoho. 1986. PMID: 3755882 Japanese.
-
Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer.World J Surg. 1993 Mar-Apr;17(2):237-41; discussion 242. doi: 10.1007/BF01658934. World J Surg. 1993. PMID: 8511920
-
Adjuvant systemic therapy for resectable breast cancer.J Clin Oncol. 1985 Feb;3(2):259-75. doi: 10.1200/JCO.1985.3.2.259. J Clin Oncol. 1985. PMID: 3881562 Review. No abstract available.
-
Systemic therapy as the initial step in the management of operable breast cancer.Surg Clin North Am. 1984 Dec;64(6):1181-91. doi: 10.1016/s0039-6109(16)43489-4. Surg Clin North Am. 1984. PMID: 6393402 Review.
Cited by
-
Management of patients with locally advanced breast cancer.Curr Oncol Rep. 2004 Jan;6(1):53-61. doi: 10.1007/s11912-996-0010-z. Curr Oncol Rep. 2004. PMID: 14664762 Review.
-
Perioperative Drug Management of Systemic Therapies in Breast Cancer: A Literature Review and Treatment Recommendations.Curr Oncol. 2025 Mar 9;32(3):154. doi: 10.3390/curroncol32030154. Curr Oncol. 2025. PMID: 40136358 Free PMC article. Review.
-
A priori prediction of tumour response to neoadjuvant chemotherapy in breast cancer patients using quantitative CT and machine learning.Sci Rep. 2020 Jul 2;10(1):10936. doi: 10.1038/s41598-020-67823-8. Sci Rep. 2020. PMID: 32616912 Free PMC article.
-
Management of locally advanced breast cancer.World J Surg. 1994 Jan-Feb;18(1):81-6. doi: 10.1007/BF00348196. World J Surg. 1994. PMID: 8197781 Review.
-
Impact of neoadjuvant chemotherapy on wound complications after breast surgery.Surgery. 2012 Sep;152(3):382-8. doi: 10.1016/j.surg.2012.05.001. Epub 2012 Jun 26. Surgery. 2012. PMID: 22739071 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical